Overview
Epistemix runs a cloud-based platform that models realistic human populations to forecast outcomes and test strategies before acting. It uses scalable simulations that blend epidemiology and computer science to show how different decisions could affect populations, supporting tasks like strategic planning, demand forecasting, resource allocation, and precision public health. The service differentiates itself with a scalable, transparent population-simulation engine designed for rigorous evaluation of large-scale impacts and trusted, data-driven results. Its goal is to help decision-makers understand potential outcomes of their choices and optimize actions for better public and organizational results.
Work here?Claim your company
Simplify's take
What believers are saying
- Epistemix partnered with Gigasheet in January 2026 for healthcare cost forecasting.
- Revelio tracked 17 active job postings in 2026, implying continued hiring momentum.
- G2 listed Epistemix with a 4.5 rating and use cases across health, CPG, government.
What critics are saying
- Nahigian Strategies sued Epistemix on May 7, 2025 in Western District Pennsylvania.
- A 2026 workforce estimate of 18 employees signals thin execution capacity against larger simulation vendors.
- If Populus sales stall beyond healthcare and public-sector niches, Epistemix remains a small services business.
What makes Epistemix unique
- Epistemix’s Populus and Polaris simulate human behavior, not generic dashboards, using synthetic populations.
- AWS highlighted Epistemix’s agent-based modeling and statistically accurate U.S. population models in November 2026.
- University of Pittsburgh roots and NIH-Gates funding give Epistemix deep epidemiology credibility.
Help us improve and share your feedback! Did you find this helpful?